These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2511231)

  • 21. Association between statin use and clinical course, microbiologic characteristics, and long-term outcome of early Lyme borreliosis. A post hoc analysis of prospective clinical trials of adult patients with erythema migrans.
    Stupica D; Bajrović FF; Blagus R; Cerar Kišek T; Collinet-Adler S; Ružić-Sabljić E; Velušček M
    PLoS One; 2021; 16(12):e0261194. PubMed ID: 34914751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of Borrelia burgdorferi from skin biopsy specimens of patients with erythema migrans.
    Mitchell PD; Reed KD; Vandermause MF; Melski JW
    Am J Clin Pathol; 1993 Jan; 99(1):104-7. PubMed ID: 8422007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Treatment of Borrelia burgdorferi infection].
    Oteo JA; Martínez de Artola V
    Enferm Infecc Microbiol Clin; 1991 Jan; 9(1):52-4. PubMed ID: 2029560
    [No Abstract]   [Full Text] [Related]  

  • 24. No detection of Borrelia burgdorferi-specific DNA in erythema migrans lesions after minocycline treatment.
    Muellegger RR; Zoechling N; Soyer HP; Hoedl S; Wienecke R; Volkenandt M; Kerl H
    Arch Dermatol; 1995 Jun; 131(6):678-82. PubMed ID: 7778919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
    Stanek G; Breier F; Menzinger G; Schaar B; Hafner M; Partsch H
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):951-6. PubMed ID: 10666807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Failure of Borrelia burgdorferi to survive in the skin of patients with antibiotic-treated Lyme disease.
    Berger BW; Johnson RC; Kodner C; Coleman L
    J Am Acad Dermatol; 1992 Jul; 27(1):34-7. PubMed ID: 1619074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of erythema migrans].
    Bjark P; Ormaasen V; Skjelmerud T
    Tidsskr Nor Laegeforen; 2008 Dec; 128(24):2844. PubMed ID: 19092956
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of the role of oral penicillin for treating Lyme disease patients with erythema migrans in the United States.
    Wormser GP; Strle F
    Diagn Microbiol Infect Dis; 2020 Aug; 97(4):115071. PubMed ID: 32473319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans.
    Smith RP; Schoen RT; Rahn DW; Sikand VK; Nowakowski J; Parenti DL; Holman MS; Persing DH; Steere AC
    Ann Intern Med; 2002 Mar; 136(6):421-8. PubMed ID: 11900494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of immunosuppression on erythema migrans. A retrospective study of clinical presentation, response to treatment and production of Borrelia antibodies in 33 patients.
    Fürst B; Glatz M; Kerl H; Müllegger RR
    Clin Exp Dermatol; 2006 Jul; 31(4):509-14. PubMed ID: 16716151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia.
    Strle F; Nadelman RB; Cimperman J; Nowakowski J; Picken RN; Schwartz I; Maraspin V; Aguero-Rosenfeld ME; Varde S; Lotric-Furlan S; Wormser GP
    Ann Intern Med; 1999 Jan; 130(1):32-6. PubMed ID: 9890847
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of a novel technique of cutaneous lavage for diagnosis of Lyme disease associated with erythema migrans.
    Wormser GP; Forseter G; Cooper D; Nowakowski J; Nadelman RB; Horowitz H; Schwartz I; Bowen SL; Campbell GL; Goldberg NS
    JAMA; 1992 Sep; 268(10):1311-3. PubMed ID: 1507378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of phenoxymethylpenicillin, amoxicillin, and doxycycline for erythema migrans in general practice. A randomized controlled trial with a 1-year follow-up.
    Eliassen KE; Reiso H; Berild D; Lindbæk M
    Clin Microbiol Infect; 2018 Dec; 24(12):1290-1296. PubMed ID: 29505880
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A perspective on the treatment of Lyme borreliosis.
    Luft BJ; Gorevic PD; Halperin JJ; Volkman DJ; Dattwyler RJ
    Rev Infect Dis; 1989; 11 Suppl 6():S1518-25. PubMed ID: 2682965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Azithromycin and doxycycline for treatment of Borrelia culture-positive erythema migrans.
    Strle F; Maraspin V; Lotric-Furlan S; Ruzić-Sabljić E; Cimperman J
    Infection; 1996; 24(1):64-8. PubMed ID: 8852473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin.
    Berger BW; Johnson RC; Kodner C; Coleman L
    J Clin Microbiol; 1992 Feb; 30(2):359-61. PubMed ID: 1537904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Has the presence or absence of Borrelia burgdorferi sensu lato as detected by skin culture any influence on the course of erythema migrans?
    Logar M; Lotric-Furlan S; Maraspin V; Cimperman J; Jurca T; Ruzić-Sabljić E; Strle F
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):945-50. PubMed ID: 10666806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. European Lyme borreliosis: 231 culture-confirmed cases involving patients with erythema migrans.
    Strle F; Nelson JA; Ruzic-Sabljic E; Cimperman J; Maraspin V; Lotric-Furlan S; Cheng Y; Picken MM; Trenholme GM; Picken RN
    Clin Infect Dis; 1996 Jul; 23(1):61-5. PubMed ID: 8816130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Borrelia burgdorferi isolates from erythema migrans.
    Hercogová J; Tománková M; Plch J; Jirous J; Hulínská D; Frösslová D; Barták P
    Arch Dermatol Res; 1993; 285(3):171-3. PubMed ID: 8503699
    [No Abstract]   [Full Text] [Related]  

  • 40. Lyme disease in Japan. Analysis of Borrelia species using rRNA gene restriction fragment length polymorphism.
    Hashimoto Y; Kawagishi N; Sakai H; Takahashi H; Matsuo S; Nakao M; Miyamoto K; Iizuka H
    Dermatology; 1995; 191(3):193-8. PubMed ID: 8534936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.